Key result
The IN-TIME study is a randomized trial designed to evaluate whether Home Monitoring improves clinical status and early detection of worsening heart failure compared to standard care over 12 months.
Why the study?
Does patient management guided by Home Monitoring analysis improve clinical outcomes in patients with congestive heart failure?
RCT (n=620)
Blinded endpoints committee
prospectively randomised
Does patient management guided by Home Monitoring analysis improve clinical outcomes in patients with congestive heart failure?
The IN-TIME study is designed to evaluate whether home monitoring of implanted devices can improve clinical outcomes in heart failure patients.
No takes yet. Share an insight, caveat, or question.
Home monitoring may aid early HF detection; leaves open whether it improves outcomes in practice.
Arya et al. (2008) conducted an RCT in congestive heart failure (n=620). Home Monitoring vs. standard care was evaluated on composite of all-cause mortality, unplanned hospitalisation due to worsening heart failure, NYHA class and patient global self assessment (Packer score). The IN-TIME study is a randomized trial designed to evaluate whether Home Monitoring improves clinical status and early detection of worsening heart failure compared to standard care over 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: